Morning Overview on MSN
A new gene-editing treatment just drove back advanced stomach and colon cancers in an early trial — by reprogramming patients’ own immune cells to hunt the tumors
Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, ...
A mature cell of one type can be turned into a mature cell of another type without the cell having to pass through an earlier stage of development. This is called direct reprogramming, a reliable but ...
A team led by researchers has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of reprogrammed neurons found by other ...
UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...
Recent clinical trials have shown promising results of transplanting these cells into individuals with Type 1 diabetes: ...
Cancer immunotherapy has advanced the field of medicine and cancer care. Specifically, immunotherapy refers to the targeted treatment of the immune system. Over the last few decades, immunotherapy has ...
Why pluripotent stem cells are worth the race The urgency around faster reprogramming is not just about lab convenience, it is about unlocking what pluripotent stem cells can actually do. Human ...
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune checkpoint inhibitor therapy, according to a preclinical study. The findings ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results